We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Discover effective strategies for managing Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition. Learn about symptoms, causes, diagnosis, treatment options, and lifestyle adjustments to improve your quality of life with HS. Get expert insights on living with and preventing HS flare-ups.
Hidradenitis Suppurativa (HS), often referred to as acne inversa, is a chronic, inflammatory skin condition characterized by painful lumps, abscesses, and sinus tracts (tunnels under the skin). These lesions typically develop in areas where skin rubs together, such as the armpits, groin, buttocks, and under the breasts. HS is not contagious and is not caused by poor hygiene. It is a complex disease that can significantly impact a person's physical and emotional well-being.
Affecting approximately 1-4% of the global population, HS often begins after puberty and can persist for many years. It tends to be more common in women and individuals with a family history of the condition. Living with HS presents unique challenges, from persistent pain and discomfort to the psychological burden of visible lesions and social stigma. However, with a thorough understanding of the condition and a proactive approach to management, individuals with HS can significantly improve their quality of life.
HS is a chronic inflammatory skin disease primarily affecting hair follicles in areas rich in apocrine sweat glands. It's believed to start with a blockage of the hair follicles, leading to inflammation and rupture. This process can cause a cascade of immune responses, resulting in the formation of deep, painful nodules and abscesses. Over time, these can rupture, drain pus, and form interconnected tunnels (sinus tracts) under the skin, eventually leading to significant scarring.
While HS can affect anyone, it is more prevalent in certain demographics. Women are three times more likely to develop HS than men, and it often presents between the ages of 20 and 40. The condition can severely impact daily life, causing chronic pain, limited mobility, and psychological distress. Many individuals with HS experience delays in diagnosis, which can lead to disease progression and increased severity. Early diagnosis and consistent management are crucial for minimizing long-term complications and improving patient outcomes.
The symptoms of HS vary widely among individuals and can range from mild to severe. They typically manifest in specific areas of the body and often progress over time if left untreated.
As HS progresses, the initial lumps can evolve into more complex and severe lesions:
HS lesions most frequently appear in areas where skin folds rub together and where there's a high concentration of apocrine sweat glands:
Beyond the visible lesions, HS can be associated with other symptoms and complications:
The exact cause of Hidradenitis Suppurativa is not fully understood, but it is believed to involve a combination of genetic, hormonal, and environmental factors that lead to inflammation and blockage of hair follicles.
Genetics play a significant role in HS. Approximately one-third of individuals with HS have a family history of the condition, suggesting a hereditary component. Specific gene mutations have been identified in some cases, which may affect the immune system's response or hair follicle development.
HS often begins after puberty, during periods of hormonal changes, and can sometimes improve after menopause. This suggests that sex hormones, particularly androgens, may influence the disease. Flare-ups can also be linked to menstrual cycles, pregnancy, and the use of certain hormonal contraceptives.
HS is considered an autoinflammatory condition, meaning there's an abnormal activation of the innate immune system. The body's immune cells mistakenly attack the hair follicles, leading to chronic inflammation. This immune dysregulation is a key component of the disease pathology.
The primary event in HS is thought to be the blockage of hair follicles, particularly those in areas prone to friction. When follicles become blocked, sebum and keratin accumulate, leading to inflammation and eventual rupture of the follicle. This inflammatory process is then perpetuated by the immune system.
HS often co-occurs with other health conditions, including:
Understanding these associations is important for comprehensive management, as treating co-existing conditions can sometimes improve HS symptoms.
Diagnosing Hidradenitis Suppurativa typically involves a thorough clinical examination by a dermatologist. There is no specific blood test or imaging study that can definitively diagnose HS, making clinical assessment crucial.
A dermatologist will examine the affected areas for characteristic lesions such as painful nodules, abscesses, sinus tracts, and scarring. They will ask about the history of your symptoms, including when they started, how often they occur, and what triggers them. Key diagnostic criteria often include:
Because HS symptoms can mimic other skin conditions, the dermatologist will also rule out other possibilities, such as:
Sometimes, a swab of draining pus may be taken to check for secondary bacterial infections, but this is not for diagnosing HS itself.
Early diagnosis of HS is critical for preventing disease progression and minimizing complications. Delayed diagnosis, which is common, can lead to more extensive scarring, more severe pain, and a greater impact on quality of life. If you suspect you have HS, seeking prompt medical attention from a dermatologist is essential.
To assess the severity of HS and guide treatment decisions, dermatologists often use the Hurley Staging System:
This staging helps healthcare providers determine the most appropriate and aggressive treatment approach.
Managing Hidradenitis Suppurativa requires a multifaceted approach, often combining medical therapies, procedures, and lifestyle adjustments. Treatment aims to reduce inflammation, prevent new lesions, heal existing ones, manage pain, and improve quality of life.
For mild HS (Hurley Stage I), topical treatments may be sufficient:
Oral medications are often used for more moderate to severe HS or when topical treatments are ineffective.
Biologic drugs are a major advancement in the treatment of moderate to severe HS (Hurley Stage II and III). These medications target specific components of the immune system involved in the inflammatory process.
Surgical interventions can be crucial for managing chronic lesions, draining abscesses, and removing affected tissue.
Understand the crucial factors influencing hernia surgery costs in India. Get insights into average expenses and what to expect.
April 18, 2026
Multiple vasopressors are kept in OT to quickly manage sudden hypotension with the most suitable drug for each clinical condition.
April 16, 2026
A GA drug list is a pre-surgery checklist of essential anaesthetic drugs, ensuring safety and readiness in the operation theatre.
April 16, 2026